An Open-label Study to Evaluate the Efficacy of Neuraminidase Inhibitor Treatment in ST-Elevation Myocardial Infarction (STEMI) Patients
Latest Information Update: 03 Apr 2024
At a glance
- Drugs Oseltamivir (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 01 Jan 2021 New trial record